Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marion Subklewe

Showing results (231-240 of 244) with videos related to

Pageof 25
Sort By:
Journal of Hematology & Oncology|August 6, 2024
Novel prognostic scoring systems for severe CRS and ICANS after anti-CD19 CAR T cells in large B-cell lymphomaPierre Sesques, Amy A Kirkwood, Mi Kwon, et al.
Leukemia|November 28, 2023
Sex-associated differences in frequencies and prognostic impact of recurrent genetic alterations in adult acute myeloid leukemia (Alliance, AMLCG)Michael Ozga, Deedra Nicolet, Krzysztof Mrózek, et al.
Leukemia|October 3, 2018
Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia-a phase 3 studyJan Braess, Susanne Amler, Karl-Anton Kreuzer, et al.
Blood|April 21, 2025
T-ICAHT: Grading and Prognostic Impact of Thrombocytopenia After CAR T-cell TherapyKai Rejeski, Jaime Sanz, Teng Fei, et al.
Nature Biotechnology|March 14, 2023
Single-cell transcriptomic atlas-guided development of CAR-T cells for the treatment of acute myeloid leukemiaAdrian Gottschlich, Moritz Thomas, Ruth Grünmeier, et al.
Blood|January 5, 2026
Time of Day of CAR T-Cell Infusion and Outcomes in Large B-Cell LymphomaDanny Luan, Ori Ben Valid, Ofrat Beyar-Katz, et al.
Blood|November 1, 2021
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working PartyMichael Heuser, Sylvie D Freeman, Gert J Ossenkoppele, et al.
The Lancet. Haematology|August 12, 2023
Standardising acute myeloid leukaemia classification systems: a perspective from a panel of international expertsRory M Shallis, Naval Daver, Jessica K Altman, et al.
Nature Medicine|March 14, 2023
A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapyChristoph K Stein-Thoeringer, Neeraj Y Saini, Eli Zamir, et al.
Blood|October 23, 2024
Antibiotic-induced loss of gut microbiome metabolic output correlates with clinical responses to CAR T-cell therapyRishika Prasad, Abdur Rehman, Lubna Rehman, et al.
Pageof 25

Showing results (231-240 of 244) with videos related to

Sort By:
Pageof 25
Journal of Hematology & Oncology|August 6, 2024
Novel prognostic scoring systems for severe CRS and ICANS after anti-CD19 CAR T cells in large B-cell lymphomaPierre Sesques, Amy A Kirkwood, Mi Kwon, et al.
Leukemia|November 28, 2023
Sex-associated differences in frequencies and prognostic impact of recurrent genetic alterations in adult acute myeloid leukemia (Alliance, AMLCG)Michael Ozga, Deedra Nicolet, Krzysztof Mrózek, et al.
Leukemia|October 3, 2018
Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia-a phase 3 studyJan Braess, Susanne Amler, Karl-Anton Kreuzer, et al.
Blood|April 21, 2025
T-ICAHT: Grading and Prognostic Impact of Thrombocytopenia After CAR T-cell TherapyKai Rejeski, Jaime Sanz, Teng Fei, et al.
Nature Biotechnology|March 14, 2023
Single-cell transcriptomic atlas-guided development of CAR-T cells for the treatment of acute myeloid leukemiaAdrian Gottschlich, Moritz Thomas, Ruth Grünmeier, et al.
Blood|January 5, 2026
Time of Day of CAR T-Cell Infusion and Outcomes in Large B-Cell LymphomaDanny Luan, Ori Ben Valid, Ofrat Beyar-Katz, et al.
Blood|November 1, 2021
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working PartyMichael Heuser, Sylvie D Freeman, Gert J Ossenkoppele, et al.
The Lancet. Haematology|August 12, 2023
Standardising acute myeloid leukaemia classification systems: a perspective from a panel of international expertsRory M Shallis, Naval Daver, Jessica K Altman, et al.
Nature Medicine|March 14, 2023
A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapyChristoph K Stein-Thoeringer, Neeraj Y Saini, Eli Zamir, et al.
Blood|October 23, 2024
Antibiotic-induced loss of gut microbiome metabolic output correlates with clinical responses to CAR T-cell therapyRishika Prasad, Abdur Rehman, Lubna Rehman, et al.
Pageof 25